Asma
Interstício Pulmonar
Doenças Vasculares Pulmonares
Nódulo Pulmonar (Rastreio Cancro do Pulmão)
Anomalias Intersticiais Pulmonares
Pré-DPOC
Na Fisiopatologia Respiratória
Marko Topalović, PhD, serves as the Chief AI Officer at Clario, a leading company specializing in technology and data solutions for clinical trials. Formerly, Marko was a CEO and founder of ArtiQ, a respiratory AI-diagnostics company. Prior to that, at the KU Leuven, Marko worked as a postdoc researcher on inventing AI-based algorithms for respiratory diagnostics and clinical trials.
He obtained a PhD degree on the topic “Artificial intelligence for pulmonary function tests” at the KU Leuven. His scientific work has contributed to many peer-reviewed publications and numerous conference presentations. Additionally, he received several international awards.
Na Imagiologia do Tórax
Na Anatomia Patológica do Pulmão
Terapêuticas minimamente invasivas e Cirurgia Robótica no Cancro do Pulmão
Kelvin Lau qualified from the University of Oxford and was awarded a doctorate for his research into tumour targeting. He was appointed as the first consultant thoracic surgeon at Barts to set up the thoracic surgery service. Together with his colleagues, they built a large and innovative programme of robotic surgery, segmentectomy, peripheral bronchoscopy, mesothelioma surgery and lung volume reduction.
In November 2015 he led the first team in Europe to successfully use the latest version of navigation bronchoscopy, and went on to do the first in the world endobronchial microwave ablation of lung tumour in February 2018. He started using Ion robotic bronchoscopy in June 2023 as part of a clinical trial to evaluate the diagnostic outcomes when combining robotic bronchoscopy with cone beam CT.
His interests include hybrid theatre, image-guidance for thoracic surgery and advanced guided bronchoscopy for therapy such as ablation. He is principal investigator for the NAVIGATE, NAVABLATE, MARS2, RAMON and Ion trials.
Clínica de Estilos de Vida Saudáveis: uma intervenção comunitária para a promoção do autocuidado na doença crónica
Fernanda da Silva (ULSGE)
Adesão Terapêutica no Doente com Patologia Respiratória Crónica
Luciana Oliveira (ULSSJ)
Um Novo Fôlego: Implantação de Válvulas Endobrônquicas em Doentes com Enfisema Pulmonar – Novos Desafios para a Prática de Enfermagem
Hugo Vieira (ULSGE)
Ventilação não invasiva nas doenças neuromusculares: quando iniciar e como otimizar?
Michelle Chatwin (Royal Brompton and Harefield NHS Foundation Trust, UK)
Particularidades da ventilação em lesões vértebro-medulares altas
Reabilitação respiratória em doentes neuromusculares e com tetraplegia: evidência e prática
Testemunho de um doente
Referenciação para transplante: todas as patologias são iguais?
Pós-transplante pulmonar: será possível personalizar a imunossupressão?
Vicky Gerovasili (Guy’s and St Thomas’ NHS Foundation Trust, UK)
Disfunção crónica de enxerto: onde estamos e para onde vamos?
Inteligência artificial e Transplante pulmonar: presente ou futuro?
Federica Meloni (Padova University, Italy)
Desafios da cessação tabágica na doença psiquiátrica
Cessação tabágica e comorbilidades: implicações para a saúde cardiometabólica
Para além do medicamento: estratégias alternativas/complementares na cessação tabágica
Tuberculose e Micobactérias Não Tuberculosas
Pneumonias
Oncologia
Drug induced sleep endoscopy: como selecionar o doente certo?
Doentes obesos com apneia do sono: cirurgia bariátrica ou novas opções farmacológicas?
CPAP: pressões reduzidas versus pressões elevadas – impacto na adesão e eficácia e outras implicações
Que fazer quando a hipersonolência persiste?
Passado: O que aprendemos com 10 anos de EMBARC
Presente: Atualizações nas orientações – Guidelines ERS 2025
Futuro: Os próximos 10 anos – inovações na abordagem das bronquiectasias
Testemunho de um doente
Derrame pleural maligno: aplicabilidade e limitações de um score preditor de prognóstico.
Position: Respiratory Consultant and Pleural Lead, Norfolk and Norwich University Hospitals
Specialties: Respiratory Medicine
Sub-Speciality: Pleural disease, lung cancer
Special Clinical Interests: Pleural disease including medical thoracoscopy, indwelling pleural catheters, malignant pleural disease, pleural infection and pneumothorax including ambulatory management.
Research Interests: Malignant pleural disease, with a particular focus on improving patient outcomes. Current research work involves prediction of rate of pleural fluid reaccumulation, patient reported outcome measure and diagnosis and management of indwelling pleural catheter infections. I am also interested in bacteriophage treatment for Pseudomonas colonisation in patients with bronchiectasis.
Current Membership of Professional, National and Regional Bodies: Committee member of UK Pleural Society responsible for organising the annual research conference; British Thoracic Society, NIHR RfPB committee member.
Universities and Degrees: MA (Cantab), MBChB (University of Oxford), DPhil (University of Oxford).
Derrame pleural de etiologia incerta: quando investigar mais e quando assumir uma conduta expectante?
Dr. Aleš Rozman is a distinguished Slovenian medical professional renowned for his extensive experience and expertise in the fields of interventional pulmonology and healthcare management. He completed his medical education at the University of Ljubljana, Slovenia, in the year 2000. Throughout his career, he held key positions such as Head of the Respiratory Endoscopy Department and Interventional Pulmonology Department at the University Clinic Golnik, as well as the CEO of the same clinic.
With over two decades of active involvement in interventional pulmonology, Aleš Rozman’s primary focus has always been advancing medical knowledge and enhancing patient care. His skillset spans across a broad spectrum, ranging from interventional pulmonology and intensive care to medical oncology. His research contributions encompass interventional pulmonology, lung cancer, interstitial lung diseases, and obstructive lung diseases. Additionally, he has taken on the role of an assistant professor at the University of Ljubljana and is dedicated to mentoring students, PhD candidates, and medical residents. Aleš is also recognized as a distinguished faculty member and a sought-after speaker at international courses and congresses dedicated to bronchology and interventional pulmonology. Aleš’s dedication to the medical community extends beyond his clinical work. He has actively participated in various appointments and boards, serving as the Head of the Slovenian Medical Council for two terms, and as a member of the National Advisory Board for COVID-19. In these roles, he has made significant contributions to important healthcare decisions in Slovenia.
Tema de encerramento
Atribuição dos prémios de melhores CO e caso clínico
Lançamento do CPN 2027
Rastreios Pré-imunossupressão: o essencial
Vacinação: Esquemas e Timing Adequado
Caso Clínico Interativo
Respirar a 10000 metros: desafios das viagens aéreas nos doentes respiratórios crónicos
O microbioma respiratório e a saúde mental: haverá um “eixo pulmão-cérebro”?
Micro e nanoplásticos no pulmão: da inalação ao impacto clínico
Silicose em Portugal: para quando a erradicação?
Receba todas as actualizações do congresso.
Obrigado pela sua inscrição nas Newsletter. Irá receber as atualizações no seu email.
Encontramo-nos no Porto.
Obrigado pela sua inscrição nas Newsletter. Irá receber as atualizações no seu email.
Encontramo-nos no Porto.
Av. Antunes Guimarães, 554
4100–074 Porto
+351 226 165 450